Weekly Carboplatin and Taxotere in Platinum Sensitive Relapsed Ovarian or Tubal or Primary Peritoneal Cancers
Stopped Regulatory issues(trial temporarily suspended December 28, 2005. Permanently suspended January 19, 2007. Institutional Reveiw Board informed April 18, 2007
Conditions
- Platinum Sensitive Relapsed Ovarian Cancer
Interventions
- DRUG: Weekly Taxotere with weekly carboplatin
Sponsor
University of Saskatchewan
Collaborators